SignatureFD’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
SignatureFD's IOVA Position: Q3 2026 in Review
SignatureFD increased its Iovance Biotherapeutics (IOVA) stake by 47% in Q3 2026, buying an estimated $3.91K and bringing the position to 1,718 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2308.
SignatureFD first reported a position in IOVA in Q2 2020 and has held it in 22 quarters since. The position peaked at $139K in Q1 2024. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- SignatureFD held 1,718 shares of Iovance Biotherapeutics worth $25.5K as of Q3 2026.
- SignatureFD bought 546 Iovance Biotherapeutics shares in Q3 2026, an estimated $3.91K.
- Iovance Biotherapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2308 holding.
- SignatureFD first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 22 quarters since.
- SignatureFD's Iovance Biotherapeutics position peaked at $139K in Q1 2024.
- 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.